Description: Shenzhen Salubris Pharmaceuticals Co., Ltd. engages in the research, development, production, and sale of medicines for cardiovascular, anti-diabetic, antineoplastic, and orthopedic therapeutic in China. It offers cardiovascular and cerebrovascular products, such as allisartan isoproxil, benazepril hydrochloride, desloratadine, and clopidogrel bisulfate tablets, as well as bivalirudin and pamidronate disodium injections; recombinant SeV-hFGF2/dF Injection for the treatment of diabetic foot disease; and anti-tumor and orthopedics medicines. The company also provides anti-infection products comprising cefonicid sodium, ceftazidime, ceftriaxone sodium, cefonicid sodium, cefminox sodium, cefuroxime sodium, cefepime hydrochloride, and cefodizime sodium injections, as well as azithromycin dispersible and levetiracetam tablets. In addition, it offers biotechnological drugs, such as recombinant protein and monoclonal antibody drugs. Further, the company is involved in import, licensing-in, and licensing-out medicines for Europe markets. The company was founded in 1998 and is headquartered in Shenzhen, China.
Home Page: www.salubris.com
NEO Greenview Plaza, Block B
Shenzhen,
China
Phone:
86 755 8386 7888
Officers
| Name | Title |
|---|---|
| Mr. Sing Ye | GM, CEO & Non Independent Director |
| Ms. Yun Kong | CFO & Financial Mang. |
| Mr. Ping Chen | Deputy Gen. Mang. |
| Mr. Jie Yan | Deputy GM & Non Independent Director |
| Mr. Jianfeng Yang | Sec. of the Board of Directors & Non Independent Director |
| Ms. Song Ping Zhao | Deputy Gen. Mang. |
| Xie Heng M.D., Ph.D. | Chief Medical Officer |
Exchange: SHE
Country: CN : China
Currency: Renminbi (¥)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 45.8716 |
|---|---|
| Trailing PE: | 58.3387 |
| Price-to-Book MRQ: | 4.5824 |
| Price-to-Sales TTM: | 10.5279 |
| IPO Date: | 2009-09-10 |
| Fiscal Year End: | December |
| Full Time Employees: | 3236 |